News
VANCOUVER, BC / ACCESS Newswire / July 8, 2025 / BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTC PINK:BNXTF)(FSE:BXT), a development-stage biopharmaceutical company specializing in ad ...
Apogee Therapeutics, Inc.'s APG777 shows promising week-16 efficacy and dosing potential, targeting the AT market. Click for ...
Scientists have discovered novel drug candidates which could ultimately lead to new effective treatments for conditions ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results